158 related articles for article (PubMed ID: 31692239)
21. Differential and tumor-specific expression of CD160 in B-cell malignancies.
Farren TW; Giustiniani J; Liu FT; Tsitsikas DA; Macey MG; Cavenagh JD; Oakervee HE; Taussig D; Newland AC; Calaminici M; Bensussan A; Jenner M; Gribben JG; Agrawal SG
Blood; 2011 Aug; 118(8):2174-83. PubMed ID: 21715317
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotyping of Chronic Lymphocytic Leukemia.
Falay M; Özet G
Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
[TBL] [Abstract][Full Text] [Related]
23. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
[TBL] [Abstract][Full Text] [Related]
25. The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry.
Myles N; Giri P; Chim I; Kodituwakku A
Leuk Lymphoma; 2021 Feb; 62(2):504-506. PubMed ID: 31559884
[No Abstract] [Full Text] [Related]
26. Concordance between flow cytometry CLL scores.
Sorigue M; Raya M; Vergara S; Junca J
Int J Lab Hematol; 2021 Aug; 43(4):743-751. PubMed ID: 33949096
[TBL] [Abstract][Full Text] [Related]
27. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
[TBL] [Abstract][Full Text] [Related]
28. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of the CLLflow score.
Sorigue M; Franch-Sarto M; Sarrate E; Junca J
Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
[TBL] [Abstract][Full Text] [Related]
30. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.
Ibrahim F; Al Sabbagh A; Amer A; Soliman DS; Al Sabah H
Am J Case Rep; 2020 Mar; 21():e921131. PubMed ID: 32150530
[TBL] [Abstract][Full Text] [Related]
31. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
32. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
33. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
34. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
Yoshino T; Tanaka T; Sato Y
J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
[TBL] [Abstract][Full Text] [Related]
36. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD43 in chronic lymphoproliferative leukemias.
Sorigue M; Juncà J; Sarrate E; Grau J
Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
[TBL] [Abstract][Full Text] [Related]
39. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
40. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
